Related Articles
Prevalence of <em>BRCA1</em> and <em>BRCA2</em> mutations in Japanese patients with triple‑negative breast cancer: A single institute retrospective study
BRCA2 germline mutations in primary cancer of the fallopian tube
Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer
First application of next‑generation sequencing in Moroccan breast/ovarian cancer families and report of a novel frameshift mutation of the BRCA1 gene
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland